FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2748812437> ?p ?o ?g. }

• W2748812437 endingPage "82" @default.
• W2748812437 startingPage "77" @default.
• W2748812437 abstract "Tadalafil is a promising phosphodiesterase (PDE) 5 inhibitor prescribed for erectile dysfunction (ED). Daily low dose (5 mg) of tadalafil has also been used for the treatment of male lower urinary tract symptoms (LUTS) associated with benign prostate hyperplasia (BPH). PDE5 inhibitors induce relaxation of smooth muscle cells in the urethra, prostate, bladder neck, and blood vessels. The aim of this study was to investigate the efficacy of tadalafil on vessels endothelial function, in patients with male LUTS symptoms associated with BPH.The Institutional Review Board (IRB) approved this clinical study and informed consents had been obtained from 81 BPH patients. The following male LUTS parameters: international prostate symptom score (IPSS), overactive bladder symptom score (OABSS), voiding volume, max and mean voiding flow on voiding flowmetry examination and post-voiding residual urine (RU) were compared at 0, 1, 3, 6, and 12 months after a daily dose of 5 mg tadalafil. In addition, erectile function was evaluated by the sexual health inventory for men (SHIM) score and vessels endothelial function and peripheral neuropathy were assessed by the brachial-ankle pulse wave velocity (baPWV), ankle brachial index (ABI), and vibration perception threshold (VPT) at 0, 3, 6, and 12 months after treatment.The mean age of 81 patients was 66.4 ± 11.4 years old. Their prostate size was 30.2 ± 22.1 ml. Male LUTS parameters including IPSS, OABSS, and RU showed significant improvement from 1 to 12 months after tadalafil administration. Max and mean voiding flow was significantly increased at 6 months after tadalafil treatment. The SHIM score showed significant improvement after 3 months. Whilst, the results of baPWV also showed significant improvement from 3 to 12 months. ABI was also significantly improved at 6 months. However, there was no change in the VPT at any time point.Tadalafil is effective for both male LUTS and ED. It is also shown that tadalafil improves baPWV, which we can conclude that higher vessels elasticity has been obtained. This major finding of this study shows that tadalafil has the potency to improve vessels endothelial dysfunction in patients with BPH." @default.
• W2748812437 created "2017-08-31" @default.
• W2748812437 creator A5015597104 @default.
• W2748812437 creator A5026837935 @default.
• W2748812437 creator A5035765057 @default.
• W2748812437 creator A5045880841 @default.
• W2748812437 creator A5051979269 @default.
• W2748812437 date "2017-08-22" @default.
• W2748812437 modified "2023-09-27" @default.
• W2748812437 title "Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia" @default.
• W2748812437 cites W1987608639 @default.
• W2748812437 cites W2013458624 @default.
• W2748812437 cites W2031626173 @default.
• W2748812437 cites W2051838969 @default.
• W2748812437 cites W2064614614 @default.
• W2748812437 cites W2065401194 @default.
• W2748812437 cites W2065853579 @default.
• W2748812437 cites W2067829754 @default.
• W2748812437 cites W2084715038 @default.
• W2748812437 cites W2094675123 @default.
• W2748812437 cites W2097777344 @default.
• W2748812437 cites W2113748458 @default.
• W2748812437 cites W2123001825 @default.
• W2748812437 cites W2125528875 @default.
• W2748812437 cites W2127997190 @default.
• W2748812437 cites W2133236743 @default.
• W2748812437 cites W2154893083 @default.
• W2748812437 cites W2170774448 @default.
• W2748812437 cites W2212852303 @default.
• W2748812437 cites W2229446155 @default.
• W2748812437 cites W2251027969 @default.
• W2748812437 cites W2338804784 @default.
• W2748812437 cites W2346136483 @default.
• W2748812437 cites W2556751863 @default.
• W2748812437 cites W2562034787 @default.
• W2748812437 cites W2592906979 @default.
• W2748812437 cites W4245421692 @default.
• W2748812437 cites W4248008753 @default.
• W2748812437 cites W1494508678 @default.
• W2748812437 doi "https://doi.org/10.1080/13685538.2017.1367922" @default.
• W2748812437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28830281" @default.
• W2748812437 hasPublicationYear "2017" @default.
• W2748812437 type Work @default.
• W2748812437 sameAs 2748812437 @default.
• W2748812437 citedByCount "27" @default.
• W2748812437 countsByYear W27488124372018 @default.
• W2748812437 countsByYear W27488124372019 @default.
• W2748812437 countsByYear W27488124372020 @default.
• W2748812437 countsByYear W27488124372021 @default.
• W2748812437 countsByYear W27488124372022 @default.
• W2748812437 countsByYear W27488124372023 @default.
• W2748812437 crossrefType "journal-article" @default.
• W2748812437 hasAuthorship W2748812437A5015597104 @default.
• W2748812437 hasAuthorship W2748812437A5026837935 @default.
• W2748812437 hasAuthorship W2748812437A5035765057 @default.
• W2748812437 hasAuthorship W2748812437A5045880841 @default.
• W2748812437 hasAuthorship W2748812437A5051979269 @default.
• W2748812437 hasConcept C121608353 @default.
• W2748812437 hasConcept C126322002 @default.
• W2748812437 hasConcept C126894567 @default.
• W2748812437 hasConcept C142724271 @default.
• W2748812437 hasConcept C204787440 @default.
• W2748812437 hasConcept C2775871022 @default.
• W2748812437 hasConcept C2776235491 @default.
• W2748812437 hasConcept C2776547966 @default.
• W2748812437 hasConcept C2778941218 @default.
• W2748812437 hasConcept C2779478474 @default.
• W2748812437 hasConcept C2779929075 @default.
• W2748812437 hasConcept C2780816001 @default.
• W2748812437 hasConcept C2781045395 @default.
• W2748812437 hasConcept C71924100 @default.
• W2748812437 hasConcept C74534348 @default.
• W2748812437 hasConcept C77411442 @default.
• W2748812437 hasConceptScore W2748812437C121608353 @default.
• W2748812437 hasConceptScore W2748812437C126322002 @default.
• W2748812437 hasConceptScore W2748812437C126894567 @default.
• W2748812437 hasConceptScore W2748812437C142724271 @default.
• W2748812437 hasConceptScore W2748812437C204787440 @default.
• W2748812437 hasConceptScore W2748812437C2775871022 @default.
• W2748812437 hasConceptScore W2748812437C2776235491 @default.
• W2748812437 hasConceptScore W2748812437C2776547966 @default.
• W2748812437 hasConceptScore W2748812437C2778941218 @default.
• W2748812437 hasConceptScore W2748812437C2779478474 @default.
• W2748812437 hasConceptScore W2748812437C2779929075 @default.
• W2748812437 hasConceptScore W2748812437C2780816001 @default.
• W2748812437 hasConceptScore W2748812437C2781045395 @default.
• W2748812437 hasConceptScore W2748812437C71924100 @default.
• W2748812437 hasConceptScore W2748812437C74534348 @default.
• W2748812437 hasConceptScore W2748812437C77411442 @default.
• W2748812437 hasIssue "1" @default.
• W2748812437 hasLocation W27488124371 @default.
• W2748812437 hasLocation W27488124372 @default.
• W2748812437 hasOpenAccess W2748812437 @default.
• W2748812437 hasPrimaryLocation W27488124371 @default.
• W2748812437 hasRelatedWork W1559582992 @default.
• W2748812437 hasRelatedWork W2046101516 @default.
• W2748812437 hasRelatedWork W2074093603 @default.
• W2748812437 hasRelatedWork W2075661281 @default.

• next